2jp6
From Proteopedia
(Difference between revisions)
Line 5: | Line 5: | ||
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2jp6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2jp6 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2jp6 RCSB], [http://www.ebi.ac.uk/pdbsum/2jp6 PDBsum]</span></td></tr> | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2jp6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2jp6 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2jp6 RCSB], [http://www.ebi.ac.uk/pdbsum/2jp6 PDBsum]</span></td></tr> | ||
</table> | </table> | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/KA181_TITCA KA181_TITCA]] Reversible blocker of both Kv1.3/KCNA3 potassium channels of human T-lymphocytes (high affinity) and Shaker B potassium channels (very low affinity).<ref>PMID:12445473</ref> | ||
==See Also== | ==See Also== | ||
*[[Potassium channel toxin|Potassium channel toxin]] | *[[Potassium channel toxin|Potassium channel toxin]] | ||
+ | == References == | ||
+ | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> |
Revision as of 09:25, 25 December 2014
Structural and functional characterization of the recombinant form of the Kv1.3 channel blocker Tc32
|